Literature DB >> 16687948

Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improves multiple cardiometabolic parameters in overweight and obese individuals.

Michael J Bloch1, Jan Basile.   

Abstract

Entities:  

Year:  2006        PMID： 16687948      PMCID： PMC8109597          DOI： 10.1111/j.1524-6175.2005.05131.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  1 in total

1.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321
  1 in total
  1 in total

1.  The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazide.

Authors:  Jinho Shin; Hae Young Lee; Wook Jin Chung; Ho Joong Youn; Eun Joo Cho; Ki Chul Sung; Shung Chull Chae; Byung Su Yoo; Chang Gyu Park; Soon-Jun Hong; Taek Jong Hong; Dong-Ju Choi; Jong Won Ha; Young Jo Kim; Young Keun Ahn; Myeong-Chan Cho; Soon Kil Kim; Sungha Park; Il-Suk Sohn; Chong-Jin Kim
Journal:  J Hypertens       Date:  2019-12       Impact factor: 4.844
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.